Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Roden

Showing results (81-90 of 1,010) with videos related to

Pageof 101
Sort By:
Current Opinion in Cardiology|June 7, 2006
Future of antiarrhythmic drugsDawood Darbar, Dan M Roden
Current Cardiology Reports|May 22, 2013
Pharmacogenomics and cardiovascular diseasePeter Weeke, Dan M Roden
Circulation|February 1, 1996
Extracellular potassium modulation of drug block of IKr. Implications for torsade de pointes and reverse use-dependenceT Yang, D M Roden
European Journal of Clinical Investigation|July 13, 2005
News in gut-brain communication: a role of peptide YY (PYY) in human obesity and following bariatric surgery?U Hanusch-Enserer, M Roden
Circulation|April 7, 2005
The US Food and Drug Administration Cardiorenal Advisory Panel and the drug approval processDan M Roden, Robert Temple
Expert Opinion on Pharmacotherapy|July 29, 2006
Pharmacogenetics of antiarrhythmic therapyDawood Darbar, Dan M Roden
Annual Review of Medicine|October 12, 2013
Applied pharmacogenomics in cardiovascular medicinePeter Weeke, Dan M Roden
Clinical Pharmacology and Therapeutics|June 1, 1989
Pharmacokinetic profile of encainideJ Turgeon, D M Roden
Annual Review of Medicine|March 12, 1999
Applications of NMR spectroscopy to study muscle glycogen metabolism in manM Roden, G I Shulman
Nature Reviews. Cardiology|April 18, 2013
Genetic mechanisms of atrial fibrillation: impact on response to treatmentDawood Darbar, Dan M Roden
Pageof 101

Showing results (81-90 of 1,010) with videos related to

Sort By:
Pageof 101
Current Opinion in Cardiology|June 7, 2006
Future of antiarrhythmic drugsDawood Darbar, Dan M Roden
Current Cardiology Reports|May 22, 2013
Pharmacogenomics and cardiovascular diseasePeter Weeke, Dan M Roden
Circulation|February 1, 1996
Extracellular potassium modulation of drug block of IKr. Implications for torsade de pointes and reverse use-dependenceT Yang, D M Roden
European Journal of Clinical Investigation|July 13, 2005
News in gut-brain communication: a role of peptide YY (PYY) in human obesity and following bariatric surgery?U Hanusch-Enserer, M Roden
Circulation|April 7, 2005
The US Food and Drug Administration Cardiorenal Advisory Panel and the drug approval processDan M Roden, Robert Temple
Expert Opinion on Pharmacotherapy|July 29, 2006
Pharmacogenetics of antiarrhythmic therapyDawood Darbar, Dan M Roden
Annual Review of Medicine|October 12, 2013
Applied pharmacogenomics in cardiovascular medicinePeter Weeke, Dan M Roden
Clinical Pharmacology and Therapeutics|June 1, 1989
Pharmacokinetic profile of encainideJ Turgeon, D M Roden
Annual Review of Medicine|March 12, 1999
Applications of NMR spectroscopy to study muscle glycogen metabolism in manM Roden, G I Shulman
Nature Reviews. Cardiology|April 18, 2013
Genetic mechanisms of atrial fibrillation: impact on response to treatmentDawood Darbar, Dan M Roden
Pageof 101